Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3

Citations Over TimeTop 1% of 2015 papers

Abstract

Honokiol (HKL) is a natural biphenolic compound derived from the bark of magnolia trees with anti-inflammatory, anti-oxidative, anti-tumour and neuroprotective properties. Here we show that HKL blocks agonist-induced and pressure overload-mediated, cardiac hypertrophic responses, and ameliorates pre-existing cardiac hypertrophy, in mice. Our data suggest that the anti-hypertrophic effects of HKL depend on activation of the deacetylase Sirt3. We demonstrate that HKL is present in mitochondria, enhances Sirt3 expression nearly twofold and suggest that HKL may bind to Sirt3 to further increase its activity. Increased Sirt3 activity is associated with reduced acetylation of mitochondrial Sirt3 substrates, MnSOD and oligomycin-sensitivity conferring protein (OSCP). HKL-treatment increases mitochondrial rate of oxygen consumption and reduces ROS synthesis in wild type, but not in Sirt3-KO cells. Moreover, HKL-treatment blocks cardiac fibroblast proliferation and differentiation to myofibroblasts in a Sirt3-dependent manner. These results suggest that HKL is a pharmacological activator of Sirt3 capable of blocking, and even reversing, the cardiac hypertrophic response.

Related Papers

• → Mitochondrial protein acetylation regulates metabolism(2012)251 cited
• → Loss of NAD-Dependent Protein Deacetylase Sirtuin-2 Alters Mitochondrial Protein Acetylation and Dysregulates Mitophagy(2016)144 cited
• → Exercise and Sirtuins: A Way to Mitochondrial Health in Skeletal Muscle(2019)122 cited
• → Nicotinamide mononucleotide alters mitochondrial dynamics by SIRT3‐dependent mechanism in male mice(2019)92 cited
• → Sirtuin- cAMP crosstalk in metabolic diseases: nucleus versus mitochondria(2018)